J. Meulbroek

发表

Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response.

J. Eldridge, T. Tice, J. Meulbroek, 1989, Advances in experimental medicine and biology.

Biodegradable microspheres: vaccine delivery system for oral immunization.

J. Eldridge, Z. Moldoveanu, T. Tice, 1989, Current topics in microbiology and immunology.

Biodegradable microspheres as a vaccine delivery system.

J. Mcghee, J. Eldridge, T. Tice, 1991, Molecular immunology.

Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches

Thomas R. Tice, J. Eldridge, T. Tice, 1990 .

ANTICORPS ANTI-CD98 ET CONJUGUÉS ANTICORPS-MÉDICAMENT

A. Phillips, J. Meulbroek, E. Reilly, 2015 .

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies

Eldridge, J. Eldridge, T. Tice, 1991, Infection and immunity.

Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605

S. Davidsen, Eric F. Johnson, N. Soni, 2009, BMC Cancer.

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.

Phenotype in Candida albicans of a disruption of the BGL 2 gene encoding a 1 , 3 = p = g I ucosyltransf erase

Goldman, C., J., 2022 .

Total synthesis and antifungal evaluation of cyclic aminohexapeptides.

Hui-ju Chen, Sheela A. Thomas, J. Plattner, 2000, Bioorganic & medicinal chemistry.

ABT-888 , an OrallyActive Poly ( ADP-Ribose ) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in PreclinicalTumorModels

Eric F. Johnson, T. DeWeese, X. Liu, 2007 .

Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.

L. Hasvold, Y. Hui, K. Marsh, 1996, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.

L. Hasvold, Y. Hui, K. Marsh, 1996, Journal of medicinal chemistry.

In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosisStrains

M. Mitten, J. Alder, A. Tovcimak, 1998, Antimicrobial Agents and Chemotherapy.

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Eric F. Johnson, T. DeWeese, X. Liu, 2007, Clinical Cancer Research.

Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position.

S. Wang, C. S. Cooper, R. Flamm, 1999, Journal of medicinal chemistry.

Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections

M. Mitten, R. Flamm, J. Alder, 2001, Antimicrobial Agents and Chemotherapy.

Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.

J. Alder, J. Meulbroek, S. Tanaka, 1996, The Journal of antimicrobial chemotherapy.

Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.

J. Alder, J. Meulbroek, J. Clement, 1994, Journal of acquired immune deficiency syndromes.

Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections

M. Mitten, N. Shipkowitz, J. Clement, 1995, Antimicrobial agents and chemotherapy.

Simultaneous expression of multiple immune complex receptors on murine thymocytes and spleen cells.

B. Andersson, J. Meulbroek, E. Lamon, 1986, Clinical immunology and immunopathology.

Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody

A. Scott, A. Phillips, E. DiGiammarino, 2015, Molecular Cancer Therapeutics.

Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate

Kedar S Vaidya, A. Scott, A. Phillips, 2018, Molecular Cancer Therapeutics.

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope

Kedar S Vaidya, A. Phillips, Dong Cheng, 2016, Molecular Cancer Therapeutics.

Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-beta-glucosyltransferase.

M. Coen, A. Sarthy, D. Frost, 1997, Microbiology.

Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.

Suoming Zhang, S. Zhang, M. Mitten, 2001, Journal of medicinal chemistry.

Dietary Supplementation with Fructooligosaccharides Increase Survival Time in a Hamster Model of Clostridium difficile-Colitis

J. Meulbroek, K. Garleb, K. Jarvis, 1997 .

Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor

Qian Zhang, L. Tucker, Jieyi Wang, 2008, Proceedings of the National Academy of Sciences.

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope

Kedar S Vaidya, A. Phillips, Dong Cheng, 2016, Molecular Cancer Therapeutics.